Evidence map›Paper›PMID 37060511›Full record

ArticleApplied health economics and health policy2023

Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment.

Jennifer R Donnan, Karissa Johnston, Michael Coombs, Maisam Najafizada, Lisa D Bishop

Open access · hybridAbstract read
In one paragraph

Article in Applied health economics and health policy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jennifer R DonnanSchool of Pharmacy, Memorial University of Newfoundland, NL, St. John's, Canada. Jennifer.donnan@mun.ca.ORCID 0000-0002-2908-0804
Karissa JohnstonSchool of Pharmacy, Memorial University of Newfoundland, NL, St. John's, Canada.ORCID 0000-0003-4570-9972
Michael CoombsSchool of Pharmacy, Memorial University of Newfoundland, NL, St. John's, Canada.
Maisam NajafizadaFaculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.ORCID 0000-0001-9195-5379
Lisa D BishopSchool of Pharmacy, Memorial University of Newfoundland, NL, St. John's, Canada.ORCID 0000-0002-4979-4222
Memorial University of Newfoundland · CA

Funding

CIHR Grant No. 201910CPV-429120
6 · The paper itself

Abstract

backgroundPhase two of cannabis legalisation in Canada brought cannabis vaping products to the market. This decision was controversial due to an outbreak of vaping cannabis use-associated lung injury. This resulted in three provinces banning the sale of cannabis vaping products causing inequitable access. This study sought to explore consumer preferences for cannabis vaping products to inform cannabis policy.

methodsWe used a discrete choice experiment to explore consumer preferences for attributes of cannabis vaping products. Attributes included type of device, price, tetrahydrocannabinol (THC) potency, vape liquid content, product recommendations and Health Canada regulation. Participants lived in Canada, were aged ≥ 19 years, and had purchased a cannabis vape in the last 12 months. A multinomial logit (MNL) model was used for the base model, and latent class analysis to assess preference sub-groups.

resultsIn total, 384 participants completed the survey; the MNL model showed that price and potency were the most important attributes. A three-group latent class model showed that ~ 40% of the sample was driven primarily by Health Canada Regulation and were willing to pay $56 more for a product that was regulated compared to one that was not. About 33% of the sample was driven by price, and 26% was driven by type of device.

conclusionWhile regulated status by Health Canada was most important to some consumers (~ 40%), nearly 60% of the sample were willing to make trade-offs in regulated status for products with a lower price. Therefore, policymakers need to consider the broader public health implications of banning cannabis vapes in some regions.

Indexed as

CannabisVapingConsumer BehaviorDronabinolHealth PolicyHumansDronabinol

Identifiers

PMID37060511
PMCPMC10232575
OpenAlexW4365810933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.